[Air embolism at the pleurodesis for air leakage after pulmonary resection].
Abstract: A 61-year-old female who was diagnosed with right lung cancer had right lower lobectomy by videoassisted thoracic surgery in June 2010. At the 7th post operative day( 7POD), the patient complained of dyspnea and chest X-ray showed right pneumothorax which...Effects of hyperbaric oxygen therapy on quality of life in maxillofacial patients with type III osteoradionecrosis.
Abstract: Over a 4-year period, 18 patients with type III osteoradionecrosis that developed an average of 55 months after radiotherapy treatment for head and neck cancers were referred for hyperbaric oxygen therapy (HBO(2)). Participants completed a questionnaire...Late-onset radiation-induced optic neuropathy after radiotherapy for nasopharyngeal carcinoma.
Abstract: Radiation-induced optic neuropathy (RION) is a rare but devastating late complication of radiotherapy, usually manifesting months to years after cancer treatment of the head and neck, resulting in rapidly progressive blindness in one or both eyes. The...Clinical Trial – Saliva, Hyperbaric Oxygen Therapy, & Gland Function: A Prospective Study
The purpose of this study is to determine if Hyperbaric Oxygen (HBO) therapy improves
salivary gland function in previously head-and-neck irradiated patients. The following will
be evaluated: salivary a-amylase, IGF-1, Thrombospondin-1, and VEGF-A concentrations, resting
and stimulated salivary flow rate and pH, and salivary buffering capacity. Demographic data,
past medical/surgical histories, social history and habits, risk factors, medication list,
nutritional status, stage and location of tumor treated, dose/duration of radiation, and time
elapsed since radiation treatment will be reviewed and recorded. Subjects will complete a
quality of life questionnaire, describe (presence/absence) dry mouth symptoms prior to HBO
therapy, and provide current A1c level, or submit to a finger stick. The following groups
will be evaluated: 1. Head-and-neck irradiated subjects with ORN (indicating HBO therapy) 2.
Subjects with other conditions indicating HBO therapy (positive control), and 3.
Head-and-neck irradiated subjects without ORN (negative control). Subjects will include 78
males or females, 18 years old and over. In total, participation will last 22 weeks.